Ryoko Kuromatsu - Concepedia

Author

Ryoko Kuromatsu

Also Known As

Kuromatsu, R., Masatoshi Tanaka, R Kuromatsu, R Ogata, R. Kuromatsu, R., Kuromatsu, RYOKO KUROMATSU, Ryoko KUROMATSU, Ryoko Kuromatsu, Tatsuya Ide

122

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Kurume University Kurume University Hospital ShinKokura Hospital Omuta hospital Kindai University

About

Ryoko Kuromatsu is an author at Kurume University specializing in medicine, pathology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.3K
2	Health Sciences	11	11	567
3	Cell Biology	2	2	70
4	Public Health	1	1	15
5	Biostatistics	1	1	15

Ryoko Kuromatsu

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors Shuji Sumie, Ryoko Kuromatsu, Koji Okuda, Annals of Surgical Oncology AngiogenesisHepatologyMedicineSurgical PathologyHistopathology	2008	384
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis Eiji Ando, Masatoshi Tanaka, F Yamashita, Cancer	2002	323
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis Thomas Yau, Chiun Hsu, Tae‐You Kim, Journal of Hepatology	2019	267
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset Tatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda, Journal of Gastroenterology	2019	217
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis Masatoshi Kudo, Ana Matilla, Armando Santoro, Journal of Hepatology	2021	215
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma Shuji Sumie, Osamu Nakashima, Koji Okuda, Annals of Surgical Oncology AngiogenesisHepatologyHepatocellular CarcinomaMedicineLiver Physiology	2013	196
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma Haruhiko Yoshida, Yasushi Shiratori, Masatoshi Kudo, Hepatology	2011	126
Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status. Masatoshi Kudo, Ana Matilla, Armando Santoro, Journal of Clinical Oncology ImmunologyPathologyImmunotherapeuticsImmunotherapyObjective Response Rate	2019	98
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis Hajime Aino, Shuji Sumie, Takashi Niizeki, Molecular and Clinical Oncology Hcc PatientsSurgical OncologyHepatologyMedicineHepatobiliary Tumor	2014	83
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Cancers	2020	75

Page 1